As a biological marker for ASD and attention deficit hyperactivity disorder (ADHD), we tested for the presence of auto-antibodies against glutamate decarboxylase (GAD65), which Rout et al. detected in 15% of ASD and 27% of ADHD children [11]. This evidence concerns the gene GAD2 and attention deficit-hyperactivity disorder.